# FDA Inspection 1122463 - Merck Serono SA - February 18, 2020

Source: https://www.keypedia.com/records/fda_inspections/merck-serono-sa/b16e50c2-a7b2-4135-b13f-17fdb67bb64d
Source feed: FDA_Inspections

> FDA Inspection 1122463 for Merck Serono SA on February 18, 2020. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1122463
- Company Name: Merck Serono SA
- Inspection Date: 2020-02-18
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1298388 - 2025-11-25](https://www.keypedia.com/records/fda_inspections/merck-serono-sa/24e72be4-1d15-4a1e-902a-3846211ca1e5)
- [FDA Inspection 1209187 - 2023-05-02](https://www.keypedia.com/records/fda_inspections/merck-serono-sa/6b498aa8-d6b6-44ac-bfc1-383effddc917)
- [FDA Inspection 1051545 - 2018-05-09](https://www.keypedia.com/records/fda_inspections/merck-serono-sa/9b6ada5e-805a-412e-b05b-6de574a13d76)
- [FDA Inspection 947757 - 2015-11-06](https://www.keypedia.com/records/fda_inspections/merck-serono-sa/3f6397d7-2aad-4229-b733-773978761e61)
- [FDA Inspection 857686 - 2013-11-12](https://www.keypedia.com/records/fda_inspections/merck-serono-sa/383cbeaf-3ced-4f97-92dd-7f9cba01f309)

Company: https://www.keypedia.com/companies/merck-serono-sa/11522eec-8d30-492a-90ba-09b167899bdc

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c